Eam Global Investors LLC Karuna Therapeutics, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $1.02 Million - $2.28 Million
8,215 New
8,215 $1.85 Million
Q3 2020

Nov 13, 2020
SELL
$71.31 - $109.74 $942,432 - $1.45 Million
-13,216 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$62.14 - $117.21 $864,367 - $1.63 Million
-13,910 Reduced 51.28%
13,216 $1.47 Million
Q1 2020

May 13, 2020
BUY
$60.41 - $115.92 $206,420 - $396,098
3,417 Added 14.41%
27,126 $1.95 Million
Q4 2019

Feb 10, 2020
BUY
$11.44 - $123.99 $271,230 - $2.94 Million
23,709 New
23,709 $1.79 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email